kumarnaidu Regular Mumbai, India, 2019-02-06 06:50 Posting: # 19878 Views: 218 |
|
Hi, We have conducted the Beclomethasone in-vitro population bioequivalence study for spray pattern test .Ten units for three batch of test and reference products were used for beginning life stage only . In this experiment, three reading were measured each canisters of beginning life stage only (m=1). My question is such case , n : Number of canisters or bottles per batch, for T and R products would be 10 or 30. According to Draft Guidance on Budesonide, Recommended Sep 2012 notation are as below: nT ,nR : Number of canisters or bottles per batch, for T and R products. lT , lR : Number of batches of T and R products Data Finalresult; set AA; GM_T=Exp(Mean_T); GM_R=Exp(Mean_R); meandiff=mean_T - mean_R; m_T=1;/* no. of stages*/ m_R=1;/* no. of stages*/ n_T=10;/* no. of bottles per batch*/ n_R=10;/* no. of bottles per batch*/ l_T=3;/* no. of batches*/ l_R=3;/* no. of batches*/ your help on this would be greatly appreciated. — Kumar Naidu |
ElMaestro Hero Denmark, 2019-02-06 08:55 @ kumarnaidu Posting: # 19879 Views: 178 |
|
Hi kumarnaidu, » We have conducted the Beclomethasone in-vitro population bioequivalence study for spray pattern test .Ten units for three batch of test and reference products were used for beginning life stage only . » » In this experiment, three reading were measured each canisters of beginning life stage only (m=1). My question is such case , n : Number of canisters or bottles per batch, for T and R products would be 10 or 30. n is the number of units per batch; in this case it sounds like you have n=10. This is usually not enough to secure a reasonable chance to show BE for nasal products and inhaled products (regardless of pMDI, DPI or nebs). — if (3) 4 Best regards, ElMaestro "(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures." New York Times (ed.), June 9, 2018. |